Evidence map›Paper›PMID 37060937›Full record

ArticleDevelopmental biology2023

Aberrant differentiation of second heart field mesoderm prefigures cellular defects in the outflow tract in response to loss of FGF8.

Sophie Astrof, Cecilia Arriagada, Yukio Saijoh, Alexandre Francou, Robert G Kelly, Anne Moon

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. In-Depth Genomic Analysis: The New Challenge in Congenital Heart Disease.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sophie AstrofDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ, USA.
Cecilia ArriagadaDepartment of Cell Biology and Molecular Medicine, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, NJ, USA.
Yukio SaijohDepartment of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT, USA.
Alexandre FrancouAix-Marseille Université, CNRS UMR 7288, Developmental Biology Institute of Marseille, Marseille, France.
Robert G KellyAix-Marseille Université, CNRS UMR 7288, Developmental Biology Institute of Marseille, Marseille, France.
Anne MoonDepartment of Molecular and Functional Genomics, Weis Center for Research, Geisinger Clinic, Danville, PA, USA; Department of Human Genetics, University of Utah, Salt Lake City, UT, USA; The Mindich Child Health and Development Institute, Hess Center for Science and Medicine at Mount Sinai, New York, NY, USA. Electronic address: ammoongrs@outlook.com.
Centre National de la Recherche Scientifique · FRRutgers, The State University of New Jersey · USGeisinger Medical Center · USUniversity of Utah · US

Funding

Role of integrin a5 in the development of aortic arch arteries.R01HL103920 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ASTROF, SOPHIE · 2010 to 2024
$5.7M
Role of fibronectin in the morphogenesis of the cardiac outflow tractR01HL134935 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI Sophie Astrof · 2017 to 2026
$2.2M
Identification of compensatory mechanisms to rescue aortic arch artery defectsR01HL158049 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ASTROF, SOPHIE · 2022 to 2025
$1.9M
American Heart Association-American Stroke Association 836254NHLBI NIH HHS R01 HL103920NHLBI NIH HHS R01 HL134935NHLBI NIH HHS R01 HL158049
6 · The paper itself

Abstract

Development of the outflow tract of the heart requires specification, proliferation and deployment of a progenitor cell population from the second heart field to generate the myocardium at the arterial pole of the heart. Disruption of these processes leads to lethal defects in rotation and septation of the outflow tract. We previously showed that Fibroblast Growth Factor 8 (FGF8) directs a signaling cascade in the second heart field that regulates critical aspects of OFT morphogenesis. Here we show that in addition to the survival and proliferation cues previously described, FGF8 provides instructive and patterning information to OFT myocardial cells and their progenitors that prevents their aberrant differentiation along a working myocardial program.

Indexed as

HeartMyocardiumAnimalsCell DifferentiationFibroblast Growth Factor 8MesodermMiceMyocytes, CardiacFibroblast Growth Factor 8

Identifiers

PMID37060937
PMCPMC10686765
OpenAlexW4365517953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.